News

Filter

Current filters:

naproxcinod

NicOx's naproxcinod gets orphan drug recommendation for Duchenne muscular dystrophy

11-09-2013

French biotechnology firm NicOx (Euronext Paris: COX) has received a positive opinion from the European…

EuropenaproxcinodNicOxPharmaceuticalRare diseasesRegulation

NicOx says it is “well funded” and has robust pipeline, despite recent disappointment with naproxcinod

20-05-2010

French biotechnology firm NicOx remains confident about its future, despite the recent negative opinion…

BiotechnologyFinancialLicensingnaproxcinodNicOxPharmaceuticalResearch

Back to top